This morning, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) disclosed the salaries of its senior managers for 2014. The compensation of president and CEO Erez Vigodman, for example, totaled $4.485 million last year, or which $1.183 million was his basic salary and $2.1 million was a cash bonus.
The salary cost of the company's chief scientific officer, Dr. Michael Hayden, totaled $5.225 million in 2014, while executive vice president and chief legal officer Richard Egosi's salary cost was $ 3.773 million.
Dr. Phillip Frost, former chairman of Teva who was replaced by Prof. Yitzhak Peterburg, had a salary cost of $900,000 last year, plus hundreds of thousands of dollars in travel costs (Frost resides in the US).
At the end of 2014, Teva employed about 43 thousand people, after laying off some 2,000 employees during the year. The company employs about 7,000 people in Israel, after 200 in Israel left in 2014.
On the capital market, last year was good not only for investors in Teva, who saw the company's share price rise, but also for the company's employees, who exercised some 11.4 million options, and pocketed some $74 million.
Published by Globes [online], Israel business news - www.globes-online.com - on February 10, 2015
© Copyright of Globes Publisher Itonut (1983) Ltd. 2015